Trade Pfizer ^PFE

Immunovant, Inc. (NASDAQ:IMVT) Q3 2026 Earnings Call Transcript

Roivant Sciences Ltd. (NASDAQ:ROIV) Q3 2025 Earnings Call Transcript

Pfizer Inc. (NYSE:PFE) Receives Average Recommendation of "Hold" from Brokerages

What Pfizer (PFE)'s Monthly GLP-1 Obesity Drug Push Means For Shareholders

Murphy Pohlad Asset Management LLC Decreases Stock Holdings in Pfizer Inc. $PFE - Daily Political

Pfizer Inc. $PFE Shares Purchased by Canada Post Corp Registered Pension Plan - Daily Political

Pfizer (NYSE:PFE) Stock Price Up 2.8% - Time to Buy?

Healthy Returns: Pfizer execs talk Metsera obesity drug

Roivant Sciences Ltd (ROIV) Q3 2025 Earnings Call Highlights: Strategic Advances and Financial ...

Unusual Options Activity Alert: 3 Stocks Setting Up for Major Profit Potential

Pfizer (NYSE:PFE) Stock Price Up 2.8% - What's Next? - Stock Observer

TrumpRx is here. This is why it won't lower drug prices for most Americans. | Morningstar

Top Pharmaceutical Stocks To Follow Now - February 6th - Daily Political

GoodRx powers pricing for leading brand medications on TrumpRx

FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need

White House debuts drug-buying site TrumpRx, with roughly 40 medications

White House launches TrumpRx discounted drug site - CBS News

Program offers significant savings on over 30 brands spannin

TrumpRx is here. Here's why it will not lower drug prices for most Americans. | Morningstar

TrumpRx's launch is hours away. Here's why it may not lower drug prices for most Americans. | Morningstar

TrumpRx, the prescription drug website, set to launch - Yahoo News Canada

Pfizer Q4 Earnings Call Highlights - Daily Political

Pfizer (NYSE:PFE) Stock Price Down 1.1% - What's Next? - Daily Political

Beacon Harbor Wealth Advisors Inc. Boosts Stock Holdings in Pfizer Inc. $PFE - Markets Daily

Pfizer's Obesity Bet PF-3944 Advances As Shares Screen Undervalued

BioPhorum announces formation of Strategic Advisory Board to accelerate industry collaboration

Pfizer (NYSE:PFE) Issues Quarterly Earnings Results - Stock Observer

Pfizer Obesity Trial Results Spark Questions On Valuation And Dividend Risk

Pfizer Inc. (PFE): A Bull Case Theory

Pfizer (NYSE:PFE) Given "Neutral" Rating at Cantor Fitzgerald - Daily Political

SBI Securities Co. Ltd. Purchases 89,822 Shares of Pfizer Inc. $PFE - Daily Political

Trump touts drug cost savings as he launches TrumpRx website | Political News | ArcaMax Publishing

Trump touts drug cost savings as he launches TrumpRx website | News & Features « ArcaMax Publishing

Pfizer (NYSE:PFE) Trading 4.1% Higher on Earnings Beat

Pfizer (PFE) Announces Positive Phase 2b Results for Obesity Drug Showing 12.30% Weight Loss

Pfizer (NYSE:PFE) Receives "Neutral" Rating from Cantor Fitzgerald

Pfizer Announces 2025 Grant Recipients Driving Innovative Solutions in Cancer Care

Pfizer Inc. (NYSE:PFE) Q4 2025 Earnings Call Transcript

Pfizer (NYSE:PFE) Releases FY 2026 Earnings Guidance

Pfizer uses 'Any Given Sunday' speech in World Cancer Day ad - Ad Age

Pfizer Q4 Earnings Call Highlights | MarketBeat

Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Avidity Biosciences (RNA) | Markets Insider

Atlantic Union Bankshares Corp Purchases 32,645 Shares of Pfizer Inc. $PFE - Daily Political

Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Pfizer (PFE) | Markets Insider

Pfizer's Obesity Drug Sparks Concerns Over Side Effects Amid Share Price Drop, ETPharma

Pfizer (NYSE:PFE) Trading Down 3.3% - Here's What Happened

Indolent primary cutaneous B-cell lymphomas resemble persistent antigen reactions without signs of dedifferentiation

Repotrectinib in NTRK fusion-positive advanced solid tumors: a phase 1/2 trial

Pfizer CEO addresses growing competition in weight-loss drugs | Fox Business Video

Pharmaceutical Stocks To Watch Now - February 3rd - Markets Daily

Pfizer's stock fell after mixed response to weight-loss data for drug set to compete with Lilly's Zepbound | Morningstar

Pfizer Earnings: Seagen Impairment and Metsera Tolerability Data Incrementally Negative | Morningstar

Pfizer's Diversified Portfolio Supports a Narrow Moat Despite an Upcoming Patent Cliff | Morningstar

Pfizer is at 'the end of the beginning' in entry to GLP-1s: CEO

Pfizer reports quarterly loss, affirms 2026 targets

Pfizer (NYSE:PFE) Shares Gap Down - What's Next?

Pfizer shares slump 3.60% on fourth quarter loss, lower 2026 outlook

Why Pfizer shares are under pressure despite a Q4 earnings beat

Pfizer Projects Revenue Dip in 2026 as Patent Losses Weigh

Pfizer's stock falls after mixed response to weight-loss data for drug set to compete with Lilly's Zepbound | Morningstar

Pfizer's Metsera GLP-1 hits mark for once-monthly dosing | BioWorld

PFE stock down after Pfizer earnings: Why is PFE stock falling today despite beating Pfizer's earnings estimates? Key factors investors are watching - The Economic Times

Pfizer (NYSE:PFE) Announces Earnings Results, Beats Estimates By $0.10 EPS

Pfizer study finds patients lose up to 12% of their weight after taking once-a-month drug | Morningstar

Pfizer beats sales estimates on demand for older drugs

Jim Cramer Expresses Concern About Pfizer Despite Its "Terrific Yield"

Jim Cramer on PepsiCo's Recent Rally: "Maybe Something's Going On" - Insider Monkey

Stocks making the biggest moves premarket: PLTR, MRK, PFE

Pfizer's monthly obesity injection drove shows promise in trial

Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook

Pfizer beats fourth-quarter profit estimates on strong drug demand

Pfizer (PFE) earnings Q4 2025

AGF Management Ltd. Lowers Position in Pfizer Inc. $PFE

Pfizer Inc. $PFE Shares Sold by Heritage Investors Management Corp

Goldman Sachs Maintains Neutral on Pfizer (PFE) Amid Rising Margin Pressure

Principal Financial Group Inc. Reduces Holdings in Pfizer Inc. $PFE

Pfizer beats Q4 projections

Pfizer (NYSE:PFE) Announces Earnings Results, Beats Expectations By $0.10 EPS - Daily Political

Pfizer (NYSE:PFE) Announces Earnings Results - Daily Political

Pfizer Q4 25 Earnings Conference Call At 10:00 AM ET

Obesity Drug Market Forecast Faces Uncertainty as Novo and Lilly Adjust Expectations, ETPharma

Altered B cell activation contributes to the immunopathogenesis of childhood arthritis-associated uveitis

Tailoring targeted therapies for younger women with ER-positive early-stage breast cancer

Pfizer News | Markets Insider

Pfizer Reshapes Portfolio With Metsera Deal Novavax Pact And R&D Push - Simply Wall St News

Is Pfizer (PFE) a Good Stock to Buy before Earnings? | Markets Insider

Health Care Up Ahead of Earnings - Health Care Roundup | Morningstar

Best Pharmaceutical Stocks To Watch Today - February 1st - Markets Daily

Option Volatility And Earnings Report For February 2 - 6

Pfizer Inc. $PFE Stock Position Lifted by Money Concepts Capital Corp

Earnings To Watch: Pfizer (PFE) Reports Q4 Results Tomorrow

Pfizer Inc. $PFE Stake Lifted by Allied Investment Advisors LLC - Daily Political

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Trump Announces 25% Tariffs on Automobiles, Pharmaceuticals, and Semiconductors

Week Ahead: US And Canada Labour Markets Are In Focus, BoE Rate Decision

Stock price forecast: 4 S&P 500 Stocks for 2025

Week ahead: Apple leads big tech earnings, UK Budget and Nonfarm Payrolls

Week ahead: Apple earnings land as Fed seen holding rates

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk